Similar articles

• Effects of chlorhexidine during immunosuppressive chemotherapy. A preliminary report.

  Rutkauskas JS, Davis JW. Rutkauskas JS, et al. Oral Surg Oral Med Oral Pathol. 1993 Oct;76(4):441-8. doi: 10.1016/0030-4220(93)90010-2. Oral Surg Oral Med Oral Pathol. 1993. PMID: 8233423 Clinical Trial.
• Evaluation of an oral preventive protocol in children with acute lymphoblastic leukemia.

  Costa EM, Fernandes MZ, Quinder LB, de Souza LB, Pinto LP. Costa EM, et al. Pesqui Odontol Bras. 2003 Apr-Jun;17(2):147-50. doi: 10.1590/s1517-74912003000200009. Epub 2003 Oct 10. Pesqui Odontol Bras. 2003. PMID: 14569357
• An efficacious oral health care protocol for immunocompromised patients.

  Solomon CS, Shaikh AB, Arendorf TM. Solomon CS, et al. Spec Care Dentist. 1995 Nov-Dec;15(6):228-33. doi: 10.1111/j.1754-4505.1995.tb00523.x. Spec Care Dentist. 1995. PMID: 9002924 Clinical Trial.
• Current practices in the oral management of the patient undergoing chemotherapy or bone marrow transplantation.

  Barker GJ. Barker GJ. Support Care Cancer. 1999 Jan;7(1):17-20. doi: 10.1007/s005200050217. Support Care Cancer. 1999. PMID: 9926969 Review.
• Oral management of the cancer patient. Part II: chemotherapy.

  Lunn R. Lunn R. Probe. 1998 Mar-Apr;32(2):58-65, 68. Probe. 1998. PMID: 9791283 Review.